Since triptolide suppressed the expression of CD44, another marker for cancer stem cells, we sought to determine, using pulmosphere assay, if the drug inhibits the proliferation and self-renewal of putative lung cancer stem cells. The gene discussed is CD44; the disease is lung cancer.